Skip to Content
Merck
CN
  • The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers.

The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers.

European journal of clinical pharmacology (1992-01-01)
B Hercelin, P Leroy, A Nicolas, C Gavriloff, D Chassard, J J Thébault, M T Reveillaud, M F Salles, P Netter
ABSTRACT

We have studied the pharmacokinetics of tiopronin and its principal metabolite, 2-mercaptopropionic acid (2-MPA) in healthy volunteers after the oral administration of 500 mg (2 Acadione tablets), followed by simultaneous assay of the two compounds in plasma over a period of 48 h using a new method (emission of fluorescence after HPLC and post-column derivatization by pyrene-maleimide). The absorption of tiopronin was slow (tmax between 4 and 6 h) and the plasma concentrations subsequently fell biexponentially. The principal metabolite 2-MPA appeared later in the plasma (tmax between 10 and 12 h after a lag-time of 3 h) then disappeared monoexponentially. About 15% of the tiopronin was metabolized to 2-MPA.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Thiolactic acid, 95%
Sigma-Aldrich
2-Mercaptopropionic acid, ≥95%, FG